---
title: The Path to US Market for Digital Health Technologies
description: Accessing the capital-rich, innovation-friendly US digital health market remains a key priority for healthtech executives the world over - but to achieve success, it is essential for companies to understand and plan for the US market's complex and evolving regulatory environment.
image: https://www.lsxleaders.com/hubfs/The%20Path%20to%20US%20Market%20for%20Digital%20Health%20Technologies.jpg
---

[![LSX The Network for Life Science Executive Leaders](https://www.lsxleaders.com/hubfs/lsx%20f.jpg "LSX The Network for Life Science Executive Leaders")](https://www.lsxleaders.com/)

![LSX Resources](https://www.lsxleaders.com/hs-fs/hubfs/Blog-2.png?width=1680&name=Blog-2.png "LSX Resources")

![LSX](https://www.lsxleaders.com/hubfs/LSX%20No%20Strap%20Square.png)

Written By   
[LSX](https://www.lsxleaders.com/blog/author/lsx)

# [The Path to US Market for Digital Health Technologies](https://www.lsxleaders.com/blog/the-path-to-us-market-for-digital-health-technologies)

[Digital Health](https://www.lsxleaders.com/blog/topic/digital-health) [Healthtech](https://www.lsxleaders.com/blog/topic/healthtech)

 9 September 2020

Accessing the capital-rich, innovation-friendly US digital health market remains a key priority for healthtech executives the world over - but to achieve success, it is essential for companies to understand and plan for the US market's complex and evolving regulatory environment.

You can also see the slides [here](https://www.lsxleaders.com/hubfs/The%20Path%20to%20US%20Market%20for%20Digital%20Health%20Technologies.pdf)

 

---------

In this session, experts from MCRA, Nicole Batista Jason Tugman, will explore and reveal best practices for entering the US market and strategies to thrive in its changing regulatory landscape.**

What we will cover:**

- Digital Health Market Growth & Future Potential
- Regulatory Considerations & Evolving Landscape
- Understanding When Regulatory Requirements are Applicable
- Risk Management & Cybersecurity

**Expert Speakers**

---

---------

**Nicole Batista**, Associate Director, Cardiovascular Regulatory Affairs, **MCRA**

![Nicole Batista, Associate Director, Cardiovascular Regulatory Affairs, MCRA 300x](https://www.lsxleaders.com/hs-fs/hubfs/Nicole%20Batista%2c%20Associate%20Director%2c%20Cardiovascular%20Regulatory%20Affairs%2c%20MCRA%20300x.png?width=100&name=Nicole%20Batista%2c%20Associate%20Director%2c%20Cardiovascular%20Regulatory%20Affairs%2c%20MCRA%20300x.png)Former FDA Assistant Director in the Division of Cardiac Electrophysiology, Diagnostics, & Monitoring Devices  
Extensive knowledge of digital health medical device regulations and policies  
Additional prior roles at FDA include Senior Lead Reviewer, Peripheral Intervention  
Devices Team and Lead Reviewer, Interventional Cardiology Devices Branch

**Jason Tugman**, Associate Director, Cybersecurity Risk Management & Strategy, **MCRA**

![Jason Tugman, Associate Director, Cybersecurity Risk Management & Strategy, MCRA 300x](https://www.lsxleaders.com/hs-fs/hubfs/Jason%20Tugman%2c%20Associate%20Director%2c%20Cybersecurity%20Risk%20Management%20%26%20Strategy%2c%20MCRA%20300x.png?width=100&name=Jason%20Tugman%2c%20Associate%20Director%2c%20Cybersecurity%20Risk%20Management%20%26%20Strategy%2c%20MCRA%20300x.png)15+ years of Cybersecurity experience with a medical and digital health focus  
Extensive experience within multiple frameworks (NIST, ISO, etc.), expertise in FDA Pre-market & Post-market Medical Device Joint Security Plan (JSP)  
An active industry speaker and leader of talks regarding FDA cybersecurity in medical devices

[![LSX](https://www.lsxleaders.com/hubfs/LSX%20No%20Strap%20Square.png)](https://www.lsxleaders.com/blog/author/lsx)

 Written By

[LSX](https://www.lsxleaders.com/blog/author/lsx)

###### Share On

[![Facebook_icon](https://www.lsxleaders.com/hubfs/Assets/Facebook.png)](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.lsxleaders.com%2Fblog%2Fthe-path-to-us-market-for-digital-health-technologies) [![Linkedin_icon](https://www.lsxleaders.com/hubfs/Assets/post_Linkedin.png)](http://www.linkedin.com/shareArticle?mini=true&url=https://www.lsxleaders.com/blog/the-path-to-us-market-for-digital-health-technologies) [![Twitter_icon](https://www.lsxleaders.com/hubfs/Assets/Blog_Twitter.png)](https://www.twitter.com/share?url=https%3A%2F%2Fwww.lsxleaders.com%2Fblog%2Fthe-path-to-us-market-for-digital-health-technologies)

### Resources

A collection of webinars, blogs and resources from LSX’s team and community – focused on connecting biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

### CATEGORIES

- [Longevity (25)](https://www.lsxleaders.com/blog/topic/longevity)
- [Ageing Well (17)](https://www.lsxleaders.com/blog/topic/ageing-well)
- [Digital Health (16)](https://www.lsxleaders.com/blog/topic/digital-health)
- [Healthtech (13)](https://www.lsxleaders.com/blog/topic/healthtech)
- [Financing Longevity (12)](https://www.lsxleaders.com/blog/topic/financing-longevity)
- [Ageing Science (11)](https://www.lsxleaders.com/blog/topic/ageing-science)
- [Medtech (5)](https://www.lsxleaders.com/blog/topic/medtech)
- [Healthcare (4)](https://www.lsxleaders.com/blog/topic/healthcare)
- [Wellness (3)](https://www.lsxleaders.com/blog/topic/wellness)
- [Preclinical (1)](https://www.lsxleaders.com/blog/topic/preclinical)

##### ABOUT

[LSX](https://www.lsxleaders.com/) is the Life Science eXecutive partnering community.

 

We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

##### EVENTS

[Female Founders](https://www.lsxleaders.com/female-founders)

[Inv€$tival Showcase](https://www.lsxleaders.com/investival-showcase)

[European Lifestars Awards](https://www.lsxleaders.com/lifestars-awards)

[LSX Nordic Congress](https://www.lsxleaders.com/lsx-nordic-congress)

[LSX USA Congress](https://www.lsxleaders.com/lsx-usa-congress)

[LSX World Congress](https://www.lsxleaders.com/lsx-world-congress)

[RNA Leaders Europe](https://www.lsxleaders.com/rna-leaders-world-congress)

[RNA Leaders USA](https://www.lsxleaders.com/rna-leaders-usa-congress)

[The $yndicate](https://www.lsxleaders.com/syndicate-investment)

[Workforce Wellbeing](https://www.lsxleaders.com/workforce-wellbeing-congress)

##### CONNECT

[Message us](https://www.lsxleaders.com/contact-us)

[Home](https://www.lsxleaders.com/)

[LSX](https://www.lsxleaders.com/)  
Informa Connect, 240 Blackfriars Road, London SE1 8BF, United Kingdom

 

[![Twitter](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-twitter.png?width=23&height=24&name=Biotech-twitter.png "Twitter")](https://twitter.com/LSXLeaders)    [![Facebook](https://www.lsxleaders.com/hs-fs/hubfs/fbook%20option%203.png?width=24&height=24&name=fbook%20option%203.png "Facebook")](https://facebook.com/LSXLeaders)    [![Youtube](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-youtube.png?width=23&height=24&name=Biotech-youtube.png "Youtube")](https://www.youtube.com/channel/UCBjBilvMaUhkgWLjQ95NIQg)    [![Linkedin](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-Linkedin.png?width=23&height=24&name=Biotech-Linkedin.png "Linkedin")](https://www.linkedin.com/company/lsx-leaders/)

 

[![Net Zero Website Logo](https://tree-nation.com/images/tracking/label-co2-website-black-en.png) ](https://tree-nation.com/profile/impact/lsx-ltd#co2)

[contact](https://www.lsxleaders.com/contact-us) | [privacy policy](https://www.lsxleaders.com/privacy-policy) | [good conduct policy](https://www.lsxleaders.com/good-conduct-policy) | [anti-slavery policy](https://www.lsxleaders.com/anti-slavery-policy) | [anti-money laundering & financial crime policy](https://www.lsxleaders.com/anti-money-laundering-financial-crime-policy) | [diversity & inclusion policy](https://www.lsxleaders.com/diversity-inclusion-policy) | [terms & conditions](https://www.lsxleaders.com/terms-conditions)  
© 2022 all rights reserved by LSX Ltd